Coronavirus Therapeutics – Volume II: Clinical Management and Public Health (Advances in Experimental Medicine and Biology, 1353) 2022 Original PDF

15 $

AUTHORS: Alexzander A. A. Asea (Editor), Punit Kaur (Editor)

Category:

Coronavirus Therapeutics – Volume II: Clinical Management and Public Health (Advances in Experimental Medicine and Biology, 1353) 2022 Original PDF

The book Coronavirus Therapeutics Volume II provides the most comprehensive review on contemporary knowledge on the consequences during the outbreak of Coronavirus. This also describes the clinical features, diagnostic evaluation and management of Coronavirus patients. Using an integrative approach to the understanding of paradigm gap in host-pathogen interaction studies to the management of Coronavirus patients in the Intensive Care Unit to the current challenges for the effective management of Coronavirus pandemic risk factors including diabetes, hypertension, obesity and repercussion on the central and peripheral nervous system.

Key basic and clinical research laboratories from major universities, academic medical hospitals, biotechnology and pharmaceutical laboratories around the world have contributed articles that review present research activity on the role of heat shock proteins in human diseases and importantly project the field into the future. The book is a must read for graduate students. medical students, basic science researchers and postdoctoral scholars in the fields of Cancer Biology, Oncology, Cardiovascular Diseases, Microbiology, Inflammation, Translational Medicine, Clinical Research, Biotechnology, Cell & Molecular Medicine, Pharmaceutical Scientists and Researchers involved in Drug Discovery.

AUTHORS: Alexzander A. A. Asea (Editor), Punit Kaur (Editor)

PAGES: 241

YEAR: 2022

PUBLICATION: Springer

LANGUAGE: English

Related Products